Dr Mark Edward Oppenlander, MD | |
19636 N 27th Ave Ste 203, Phoenix, AZ 85027-4022 | |
(235) 625-0506 | |
(623) 562-5051 |
Full Name | Dr Mark Edward Oppenlander |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 16 Years |
Location | 19636 N 27th Ave Ste 203, Phoenix, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033373998 | NPI | - | NPPES |
155583 | Medicaid | AZ |
Facility Name | Location | Facility Type |
---|---|---|
Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Neurosurgical Associates Ltd | 8820993967 | 78 |
News Archive
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.Richard P. Phipps, Ph.D., found that the same molecules used in drugs that treat diabetes also stimulate B cells in the immune system, pushing them to make antibodies for protection against invading microorganisms.
Depression is common among individuals on dialysis for kidney disease, but behavioral therapy can significantly improve their quality of life, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
A controversial Indian patents bill could threaten the lives of millions of people worldwide living with HIV-AIDS and cancer by banning companies from producing cheap copies of brand name drugs.
Leucadia National Corporation announced today that it has entered into a voting and support agreement with Lundin Mining Corporation pursuant to which, and subject to the terms thereof, it has agreed to vote all of the common shares of Inmet Mining Corporation beneficially owned by it in favour of an amalgamation of Inmet and Lundin to be effected by way of a plan of arrangement under section 192 of the Canada Business Corporations Act.
In today's fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year's Drug Delivery to the Lungs 20 (DDL 20) meeting, experts from ChemImage Corporation, will be on hand to discuss our patented chemical imaging technology and how ingredient-specific particle sizing (ISPS) fulfils precisely this requirement for drug particle size data.
› Verified 4 days ago
Entity Name | Neurosurgical Associates Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043202484 PECOS PAC ID: 8820993967 Enrollment ID: O20031203000219 |
News Archive
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.Richard P. Phipps, Ph.D., found that the same molecules used in drugs that treat diabetes also stimulate B cells in the immune system, pushing them to make antibodies for protection against invading microorganisms.
Depression is common among individuals on dialysis for kidney disease, but behavioral therapy can significantly improve their quality of life, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
A controversial Indian patents bill could threaten the lives of millions of people worldwide living with HIV-AIDS and cancer by banning companies from producing cheap copies of brand name drugs.
Leucadia National Corporation announced today that it has entered into a voting and support agreement with Lundin Mining Corporation pursuant to which, and subject to the terms thereof, it has agreed to vote all of the common shares of Inmet Mining Corporation beneficially owned by it in favour of an amalgamation of Inmet and Lundin to be effected by way of a plan of arrangement under section 192 of the Canada Business Corporations Act.
In today's fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year's Drug Delivery to the Lungs 20 (DDL 20) meeting, experts from ChemImage Corporation, will be on hand to discuss our patented chemical imaging technology and how ingredient-specific particle sizing (ISPS) fulfils precisely this requirement for drug particle size data.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark Edward Oppenlander, MD 19636 N 27th Ave Ste 203, Phoenix, AZ 85027-4022 Ph: (623) 562-5050 | Dr Mark Edward Oppenlander, MD 19636 N 27th Ave Ste 203, Phoenix, AZ 85027-4022 Ph: (235) 625-0506 |
News Archive
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.Richard P. Phipps, Ph.D., found that the same molecules used in drugs that treat diabetes also stimulate B cells in the immune system, pushing them to make antibodies for protection against invading microorganisms.
Depression is common among individuals on dialysis for kidney disease, but behavioral therapy can significantly improve their quality of life, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
A controversial Indian patents bill could threaten the lives of millions of people worldwide living with HIV-AIDS and cancer by banning companies from producing cheap copies of brand name drugs.
Leucadia National Corporation announced today that it has entered into a voting and support agreement with Lundin Mining Corporation pursuant to which, and subject to the terms thereof, it has agreed to vote all of the common shares of Inmet Mining Corporation beneficially owned by it in favour of an amalgamation of Inmet and Lundin to be effected by way of a plan of arrangement under section 192 of the Canada Business Corporations Act.
In today's fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year's Drug Delivery to the Lungs 20 (DDL 20) meeting, experts from ChemImage Corporation, will be on hand to discuss our patented chemical imaging technology and how ingredient-specific particle sizing (ISPS) fulfils precisely this requirement for drug particle size data.
› Verified 4 days ago
Curtis A Dickman, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2910 N 3rd Ave, Phoenix, AZ 85013 Phone: 602-406-3632 Fax: 602-406-4187 | |
Dr. Naresh P Patel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
James Zhou, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 350 W Thomas Rd, Phoenix, AZ 85013 Phone: 602-406-4958 | |
Dr. Erik I Curtis, M.D., M.S. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 E Highland Ave Ste 222, Phoenix, AZ 85016 Phone: 602-603-0971 | |
Dr. Michael T Lawton, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave, Phoenix, AZ 85013 Phone: 602-406-3489 Fax: 602-406-4402 | |
Dr. Jonathan Seth Hott, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 9225 N 3rd St, Suite 100, Phoenix, AZ 85020 Phone: 602-943-4509 Fax: 602-943-0348 |